FTC and FDA Sent Warning Letters to Companies Advertising Products that Claim Treatment of Disease
The Bottom Line The FTC and FDA are aggressively reviewing companies’ websites and social media channels for false or unsubstantiated health claims and efficacy claims. Advertisements on company websites and in social media posts must avoid false or unsubstantiated health claims, and efficacy Continue Reading
Advertising Week Europe | Going Global 4.0
Davis+Gilbert is once again, a proud partner of Advertising Week Europe 2018, taking place in London March 19-22. Ronald R. Urbach, Chairman of the firm and Co-Chair of the Advertising + Marketing practice group, will moderate the "Going Global 4.0" panel on Wednesday, March 21. Program Continue Reading